The DOI matches its Crossref record; 392 of the 392 references it cites were found in a registry or an index.
Diabetic neuropathy: Mechanisms to management
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–392 of 392
Huang, J. T.-J., Verkhratsky, A., & Fernyhough, P. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.08.009 · Cited by 148
Symptom Profiles Differ in Patients With Neuropathic Versus Non-neuropathic Pain
Dworkin, R. H., Jensen, M. P., Gammaitoni, A. R., Olaleye, D. O., & Galer, B. S. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.06.005 · Cited by 145
Hellweg, R., Raivich, G., Hartung, H.-D., et al. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1181 · Cited by 145
Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord
Sugimoto, K., Murakawa, Y., & Sima, A. A. F. (2002) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2002.02005.x · Cited by 144
Pkc-Drs, G. B. (2005) · Clinical Diabetology · Cited by 144
Phenytoin in the treatment of diabetic symmetrical polyneuropathy
Saudek, C. D., Werns, S. W., & Reidenberg, M. M. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977222196 · Cited by 143
Aldose Reductase in Diabetic Microvascular Complications
Chung, S. S. M., & Chung, S. S. M. (2005) · Current Drug Targets · doi:10.2174/1389450054021891 · Cited by 143
Vascular Dysfunction in Aging: Potential Effects of Resveratrol, an Anti- Inflammatory Phytoestrogen
Labinskyy, N., Csiszár, A., Veress, G., Stef, G., Pacher, P., Oroszi, G., WU, J. M., & Ungvari, Z. I. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360987 · Cited by 143
ROLE OF MACROPHAGES IN COMPLICATIONS OF TYPE 2 DIABETES
Tesch, G. H. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04729.x · Cited by 142
Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory Neuropathy
Ilnytska, O., Lyzogubov, V. V., Stevens, M. J., Drel, V. R., Mashtalir, N., Pacher, P., Yorek, M. A., & Obrosova, I. G. (2006) · Diabetes · doi:10.2337/db06-0067 · Cited by 141
Kellogg, A. P., Wiggin, T. D., Larkin, D. D., Hayes, J. M., Stevens, M. J., & Pop‐Busui, R. (2007) · Diabetes · doi:10.2337/db07-0740 · Cited by 140
Chen, Y., Yan, S. S., Colgan, J. D., Zhang, H.-P., Luban, J., Schmidt, A. M., Stern, D. M., & Herold, K. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1399 · Cited by 139
Leinninger, G. M., Backus, C., Sastry, A. M., Yi, Y., Wang, C.-W., & Feldman, E. L. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.017 · Cited by 138
Self-citationSindrup, S. H., Gram, L. F., Skjold, T., Grodum, E., Brøsen, K., & Beck‐Nielsen, H. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03836.x · Cited by 138
Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy.
Vs, C., & Ms, M. (1978) · PubMed · Cited by 138
Boulton, A. J. M., Levin, S., & Comstock, J. P. (1990) · Diabetologia · doi:10.1007/bf00404095 · Cited by 137
Coppey, L. J., Davidson, E. P., Rinehart, T. W., Gellett, J. S., Oltman, C. L., Lund, D. D., & Yorek, M. A. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0885 · Cited by 137
Maser, R. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.6.1218 · Cited by 136
Pathogenesis of Diabetic Neuropathy
Stevens, M. J., Feldman, E. L., Thomas, T. P., & Greene, D. A. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_2 · Cited by 135
Self-citationInsulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms
Sugimoto, K., Murakawa, Y., Zhang, W., Xu, G. G., & Sima, A. A. F. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200009/10)16:5<354::aid-dmrr149>3.0.co;2-h · Cited by 135
Mechanisms of Disease: mitochondria as new therapeutic targets in diabetic neuropathy
Leinninger, G. M., Edwards, J. L., Lipshaw, M. J., & Feldman, E. L. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0320 · Cited by 134
Self-citationConcentration-response relationship in imipramine treatment of diabetic neuropathy symptoms
Sindrup, S. H., Gram, L. F., Skjold, T., Frøland, A., & Beck-Nielsen, H. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.65 · Cited by 134
Resveratrol enhances insulin secretion by blocking KATP and KV channels of beta cells
Chen, W., Chi, T.-C., Chuang, L., & Su, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.062 · Cited by 134
Gabapentin vs. Amitriptyline in Painful Diabetic Neuropathy
Dallocchio, C., Buffa, C., Mazzarello, P., & Chiroli, S. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00181-0 · Cited by 131
Azad, N., Emanuele, N., Abraira, C., Henderson, W. G., Colwell, J. A., Levin, S. R., Nuttall, F. Q., Comstock, J. P., Sawin, C. T., Silbert, C. K., et al. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00062-8 · Cited by 130
Comparison of distal sympathetic with vagal function in diabetic neuropathy
Low, P. A., Zimmerman, B. R., & Dyck, P. J. B. (1986) · Muscle & Nerve · doi:10.1002/mus.880090703 · Cited by 130
Schmid, H., Henger, A., Cohen, C. D., Frach, K., Gröne, H., Schlöndorff, D., & Kretzler, M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000090745.85482.06 · Cited by 130
Cotter, M. A., & Cameron, N. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00508-3 · Cited by 129
Antioxidant activity of Tinospora cordifolia roots in experimental diabetes
Prince, P. S. M., & Menon, V. P. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00164-0 · Cited by 129
Bril, V., Buchanan, R. A., & the Ranirestat Study Group* (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1447 · Cited by 128
Edwards, A., Faux, M. C., Scott, J. D., & Newton, A. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6461 · Cited by 127
Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study
Kochar, D. K., Rawat, N., Agrawal, R. P., Vyas, A., Beniwal, R., Kochar, S. K., & Garg, P. (2003) · QJM · doi:10.1093/qjmed/hch007 · Cited by 127
Cohen, C. D., Klingenhoff, A., Boucherot, A., Nitsche, A., Henger, A., Brunner, B., Schmid, H., Merkle, M., Saleem, M. A., Koller, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511257103 · Cited by 125
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy
Freeman, R. L., Raskin, P., Hewitt, D., Vorsanger, G., Jordan, D. M., Xiang, J. X., Rosenthal, N. R., & for the CAPSS-237 Study Group (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x162674 · Cited by 125
Diemel, L. T., Brewster, W. J., Fernyhough, P., & Tomlinson, D. R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90391-3 · Cited by 124
Obrosova, I. G., Drel, V. R., Oltman, C. L., Mashtalir, N., Tibrewala, J., Groves, J. T., & Yorek, M. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00479.2007 · Cited by 124
Manzella, D., Barbieri, M., Ragno, E., & Paolisso, G. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1052 · Cited by 123
Coppini, D. V., Bowtell, P., Weng, C., Young, P. J., & Sönksen, P. H. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00170-5 · Cited by 123
Palumbo, P. J., Elveback, L. R., & Whisnant, J. P. (1978) · PubMed · Cited by 122
Pertovaara, A., Wei, H., Kalmari, J., & Ruotsalainen, M. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7574 · Cited by 122
The Effect of Oxidation on Sorbitol Pathway Kinetics
Barnett, P. A., González, R. G., Chylack, L. T., & Cheng, H. (1986) · Diabetes · doi:10.2337/diab.35.4.426 · Cited by 121
Self-citationCombination pharmacotherapy for neuropathic pain: current evidence and future directions
Gilron, I., & Max, M. B. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.6.823 · Cited by 120
Will, J. C., Ford, E. S., & Bowman, B. A. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.1.49 · Cited by 116
Near nerve local insulin prevents conduction slowing in experimental diabetes
Singhal, A., Cheng, C., Sun, H., & Zochodne, D. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00412-5 · Cited by 114
Human Recombinant Nerve Growth Factor Replaces Deficient Neurotrophic Support in the Diabetic Rat
Fernyhough, P., Diemel, L. T., Hardy, J., Brewster, W. J., Mohiuddin, L., & Tomlinson, D. R. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01098.x · Cited by 114
Ishii, D. N., & Lupien, S. B. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400116 · Cited by 113
Prolonged QT interval as a predictor of mortality in diabetic nephropathy
Sawicki, P. T., DÄhne, R., Bender, R., & Berger, M. (1996) · Diabetologia · doi:10.1007/bf00400416 · Cited by 112
Efficacy and Safety of Nonsteroidal Anti-inflammatory Drugs in the Therapy of Diabetic Neuropathy
Cohen, K. L., & Harris, S. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370080078016 · Cited by 112
Sagara, M., Satoh, J., Wada, R., Yagihashi, S., Takahashi, K., Fukuzawa, M., Muto, G., Muto, Y., & Toyota, T. (1996) · Diabetologia · doi:10.1007/bf00418340 · Cited by 110
Yagihashi, S., Kamijo, M., Ido, Y., & Mirrlees, D. J. (1990) · Diabetes · doi:10.2337/diab.39.6.690 · Cited by 110
Mexiletine: A Review of its Therapeutic Use in Painful Diabetic Neuropathy
Jarvis, B., & Coukell, A. J. (1998) · Drugs · doi:10.2165/00003495-199856040-00016 · Cited by 108
ABNORMAL CIRCADIAN RHYTHM OF MELATONIN IN DIABETIC AUTONOMIC NEUROPATHY
O'Brien, I. A. D., Lewin, I. G., OʼHARE, J. P., Arendt, J., & Corrall, R. J. M. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb01639.x · Cited by 108
Ziegler, D., Gries, F. A., Mühlen, H., Rathmann, W., Spüler, M., & Lessmann, F. (1993) · PubMed · Cited by 108
Schmidt, R. E., Dorsey, D. A., Beaudet, L. N., & Peterson, R. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63626-7 · Cited by 107
Sindrup, S. H., Ejlertsen, B., Fr�land, A., Sindrup, E., Br�sen, K., & Gram, L. F. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558223 · Cited by 107
Effects of Proinsulin C-Peptide in Experimental Diabetic Neuropathy
Cotter, M. A., Ekberg, K., Wahren, J., & Cameron, N. E. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1812 · Cited by 107
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes
Toth, C. C., Brussee, V., & Zochodne, D. W. (2006) · Diabetologia · doi:10.1007/s00125-006-0169-8 · Cited by 106
Fernyhough, P., Diemel, L. T., Brewster, W. J., & Tomlinson, D. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031231.x · Cited by 106
Hounsom, L., Horrobin, D. F., Tritschler, H., Corder, R., & Tomlinson, D. R. (1998) · Diabetologia · doi:10.1007/s001250050996 · Cited by 105
Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats
Edelstein, D., & Brownlee, M. (1992) · Diabetologia · doi:10.1007/bf00400859 · Cited by 105
Cohen, J. A., Jeffers, B. W., Faldut, D., Marcoux, M., & Schrier, R. W. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199801)21:1<72::aid-mus10>3.0.co;2-2 · Cited by 104
Protein kinase C modulates insulin action in human skeletal muscle
Cortright, R. N., Azevedo, J. L., Zhou, Q., Sinha, M. K., Pories, W. J., Itani, S. I., & Dohm, G. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e553 · Cited by 104
González‐Clemente, J. M., Mauricio, D., Richart, C., Broch, M., Caixàs, A., Megía, A., Giménez‐Palop, O., Simón, I., Martínez-Riquelme, A., Giménez‐Pérez, G., et al. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02376.x · Cited by 103
Neuropathy profile of diabetic patients in a pancreas transplantation program
Kennedy, W. R., Navarro, X., & Sutherland, D. E. R. (1995) · Neurology · doi:10.1212/wnl.45.4.773 · Cited by 103
Cooper, M. E., Thallas, V., Forbes, J. M., Scalbert, E., Sastra, S. A., Darby, I. A., & Soulis, T. (2000) · Diabetologia · doi:10.1007/s001250051355 · Cited by 102
Cameron, N. E., Leonard, M., Ross, I. S., & Whiting, P. H. (1986) · Diabetologia · doi:10.1007/bf02427088 · Cited by 102
Jacobs, E. J., Henion, A. K., Briggs, P. J., Connell, C. J., McCullough, M. L., Jonas, C. R., Rodríguez, C., Calle, E. E., & Thun, M. J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf147 · Cited by 102
The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens
Kinoshita, J. H., Dvornik, D., Kramil, M., et al. (1968) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(68)90305-x · Cited by 100
NO Pain: Potential Roles of Nitric Oxide in Neuropathic Pain
Levy, D., & Zochodne, D. W. (2004) · Pain Practice · doi:10.1111/j.1533-2500.2004.04002.x · Cited by 99
Cameron, N. E., Tuck, Z., McCabe, L., & Cotter, M. A. (2001) · Diabetologia · doi:10.1007/s001250100626 · Cited by 97
Christianson, J. A., Ryals, J. M., Johnson, M. S., Dobrowsky, R. T., & Wright, D. E. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.064 · Cited by 96
Ford, I., Cotter, M. A., Cameron, N. E., & Greaves, M. (2001) · Metabolism · doi:10.1053/meta.2001.24914 · Cited by 96
New Insights into the Mechanisms of Diabetic Neuropathy
Vincent, A. M., & Feldman, E. L. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000032411.11422.e0 · Cited by 95
Self-citationWang, Y., Schmeichel, A. M., Iida, H., Schmelzer, J. D., & Low, P. A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.03.011 · Cited by 95
Fernyhough, P., Diemel, L. T., Brewster, W. J., & Tomlinson, D. R. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90368-9 · Cited by 94
Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy.
Gomez-Perez, F. J., Choza, R., Ríos, J. M., Reza, A., Huerta, E. J. D., Aguilar, C. A., & Rull, J. A. (1996) · PubMed · Cited by 93
Effects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy
Wada, R., Nishizawa, Y., Yagihashi, N., Takeuchi, M., Ishikawa, Y., YASUMURA, K., Nakano, M., & Yagihashi, S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00826.x · Cited by 93
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study
Beydoun, A. A., Shaibani, A. I., Hopwood, M. B., & Wan, Y. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00631.x · Cited by 92
Zhuang, H.-X., Wuarin, L., Fei, Z., & Ishii, D. N. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37002-8 · Cited by 90
Demaine, A. G. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457359 · Cited by 89
Pop‐Busui, R., Sullivan, K. A., Huysen, C. V., Bayer, L., Cao, X., Towns, R., & Stevens, M. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7591 · Cited by 89
Can VEGF reverse diabetic neuropathy in human subjects?
Veves, A., & King, G. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13038 · Cited by 88
Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen
Robert, B., & Harding, J. J. (1992) · Experimental Eye Research · doi:10.1016/0014-4835(92)90129-g · Cited by 88
Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic Rats
Stevens, M. J., Li, F. R., Drel, V. R., Abatan, O. I., Kim, H., Burnett, D., Larkin, D. D., & Obrosova, I. G. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109702 · Cited by 88
Sharma, S., Kulkarni, S. K., & Chopra, K. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00455.x · Cited by 87
Diabetic neuropathy in children and adolescents
Trotta, D., Verrotti, A., Salladini, C., & Chiarelli, F. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00041.x · Cited by 87
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy
Tütüncü, N. B., Batur, M. K., Yı́ldı́rı́r, A., Tütüncü, T., Deger, A., Koray, Z., Erbaş, B., Kabakçı, G., Aksöyek, S., & Erbas, T. A. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00213.x · Cited by 87
Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease
Bongioanni, P., Reali, C., & Sogos, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004302.pub2 · Cited by 86
Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats
Li, F., Abatan, O. I., Kim, H. S., Burnett, D., Larkin, D. D., Obrosova, I. G., & Stevens, M. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.012 · Cited by 85
Eriksson, J. G., Forsén, T., Mortensen, S. A., & Rohde, M. (1999) · BioFactors · doi:10.1002/biof.5520090229 · Cited by 85
RAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease
Hudson, B. I., & Schmidt, A. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032992.75423.9b · Cited by 84
Insulin-like Growth Factor I Reverses Experimental Diabetic Autonomic Neuropathy
Schmidt, R. E., Dorsey, D. A., Beaudet, L. N., Plurad, S. B., Parvin, C. A., & Miller, M. S. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65480-6 · Cited by 84
Yamagishi, S., Ogasawara, S., Mizukami, H., Yajima, N., Wada, R., Sugawara, A., & Yagihashi, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05050.x · Cited by 84
The Effect of Pancreatic Islet Transplantation on Progression of Diabetic Retinopathy and Neuropathy
Lee, T. C., Barshes, N. R., O'Mahony, C. A., Nguyen, L. H., Brunicardi, F. C., Ricordi, C., Alejandro, R., Schock, A. P., Mote, A., & Goss, J. A. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.03.011 · Cited by 84
Li, F., Drel, V. R., Szabó, C., Stevens, M. J., & Obrosova, I. G. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1514 · Cited by 84
Hellweg, R., WOEHRLE, M., Hartung, H.-D., Stracke, H. H. G., Höck, C., & Federlin, K. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90114-9 · Cited by 83
Yang, S., Litchfield, J., & Baynes, J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00015-8 · Cited by 81
Botanicals and Dietary Supplements in Diabetic Peripheral Neuropathy
Halat, K. M., & Dennehy, C. E. (2003) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.16.1.47 · Cited by 81
Unger, J. W., Klitzsch, T., Pera, S., & Reiter, R. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6856 · Cited by 79
Hammes, H., Str�dter, D., Weiss, A., Bretzel, R. G., Federlin, K., & Brownlee, M. (1995) · Diabetologia · doi:10.1007/bf00401835 · Cited by 78
Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes
Kamiya, H., Murakawa, Y., Zhang, W., & Sima, A. A. F. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.541 · Cited by 77
Criteria for Creating and Assessing Mouse Models of Diabetic Neuropathy
Feldman, E. L., Sullivan, K., Lentz, S. I., & Roberts, J. (2008) · Current Drug Targets · doi:10.2174/138945008783431763 · Cited by 77
Self-citationWinkler, G., Pál, B., Nagybégányi, E., Őry, I., Porochnavec, M., & Kempler, P. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300405 · Cited by 76
Kellogg, A. P., & Pop‐Busui, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1521 · Cited by 76
WEINZIMER, S. A., Xing, D., Tansey, M., Fiallo-Scharer, R. V., Mauras, N., Wysocki, T., Beck, R. W., Tamborlane, W. V., & Ruedy, K. J. (2008) · Diabetes Care · doi:10.2337/dc07-1995 · Cited by 75
Pierson, C. R., Zhang, W., Murakawa, Y., & Sima, A. A. F. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.3.260 · Cited by 74
Uehara, K., Yamagishi, S., Otsuki, S., Chin, S., & Yagihashi, S. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3239 · Cited by 74
Prevention and Reversal of Diabetic Nephropathy in db/db Mice Treated with Alagebrium (ALT-711)
Peppa, Μ., Brem, H., Cai, W., Zhang, J.-G., Basgen, J. M., Li, Z., Vlassara, H., & Uribarri, J. (2006) · American Journal of Nephrology · doi:10.1159/000095786 · Cited by 74
Conti, G., Scarpini, E., Baron, P., Livraghi, S., Tiriticco, M., Bianchi, R., Vedeler, C., & Scarlato, G. (2002) · Journal of Neurological Sciences · doi:10.1016/s0022-510x(01)00684-0 · Cited by 73
Inflammatory mediators in diabetic and non-diabetic lumbosacral radiculoplexus neuropathy
Kawamura, N., Dyck, P. J. B., Schmeichel, A. M., Engelstad, J. K., Low, P. A., & Dyck, P. J. B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0326-2 · Cited by 73
Sima, A., Zhang, W., Li, Z.-G., Murakawa, Y., & Pierson, C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1556 · Cited by 71
C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes
Kamiya, H., Zhang, W., Ekberg, K., Wahren, J., & Sima, A. A. F. (2006) · Diabetes · doi:10.2337/db06-0396 · Cited by 70
Emerging roles of insulin-like growth factor-I in the adult brain
Fernández, S., Fernandez, A. M., López-López, C., & Torres‐Alemán, I. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.01.006 · Cited by 69
Diabetes in the New Millennium
Turtle, J. R., Kaneko, T., & Osato, S. (1999) · Medical Entomology and Zoology · Cited by 68
Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes
Coughlan, M. T., Forbes, J. M., & Cooper, M. E. (2007) · Kidney International · doi:10.1038/sj.ki.5002387 · Cited by 68
Ellenberg and Rifkins Diabetes Mellitus
Janeway, C., & Wong, F. S. (2002) · Cited by 68
Hasnis, E., Bar‐Shai, M., Burbea, Z., & Reznick, A. Z. (2007) · PubMed · Cited by 68
Polyneuropathy with impaired glucose tolerance: Implications for diagnosis and therapy
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2005) · Current Treatment Options in Neurology · doi:10.1007/s11940-005-0004-4 · Cited by 67
Self-citationAcute-phase proteins among patients with type 1 diabetes
Gomes, M. B., Piccirillo, L. J., Nogueira, V., & Matos, H. J. D. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70051-4 · Cited by 67
ACE inhibition salvages the visual loss caused by diabetes
Bui, B. V., Armitage, J. A., Tolcos, M., Cooper, M. E., & Vingrys, A. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1042-7 · Cited by 66
New developments in diabetic neuropathy
Sullivan, K. A., & Feldman, E. L. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000178825.56414.52 · Cited by 66
Self-citationMatsunaga, A., Kawamoto, M., Shiraishi, S., Yasuda, T., Kajiyama, S., Kurita, S., & Yuge, O. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.072 · Cited by 66
The Antioxidant Response as a Drug Target in Diabetic Neuropathy
Vincent, A. M., Edwards, J. L., Sadidi, M., & Feldman, E. L. (2008) · Current Drug Targets · doi:10.2174/138945008783431754 · Cited by 66
Self-citationMizisin, A. P., Vu, Y., Shuff, M., & Calcutt, N. A. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1807 · Cited by 66
Foster, T. S. (2007) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721706297450 · Cited by 65
Yamagishi, S., Uehara, K., Otsuki, S., & Yagihashi, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02011.x · Cited by 65
Crosby, S. R., Tsigos, C., Anderton, C. D., Gordon, C., Young, R. J., & White, A. E. (1992) · Diabetologia · doi:10.1007/bf00399934 · Cited by 65
Growth Factors as Therapeutics for Diabetic Neuropathy
Calcutt, N. A., Jolivalt, C. G., & Fernyhough, P. (2008) · Current Drug Targets · doi:10.2174/138945008783431727 · Cited by 65
Oral sildenafil in the treatment of erectile dysfunction in diabetic men
Safarinejad, M. R. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00056-4 · Cited by 63
Sayyed, S. G., Kumar, A., & Sharma, S. S. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.033 · Cited by 62
Treatment of Diabetic Polyneuropathy
Ziegler, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.008 · Cited by 61
Atli, A., & Dogra, S. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.05035.x · Cited by 61
Thomas, P. K. (1999) · European Neurology · doi:10.1159/000052078 · Cited by 60
CNTF, a pleiotropic cytokine: emphasis on its myotrophic role
Vergara, C., & Ramírez, B. U. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.010 · Cited by 60
Currie, C. J., Poole, C., Woehl, A., Morgan, C. L., Cawley, S., Rousculp, M. D., Covington, M., & Peters, J. R. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.02057.x · Cited by 60
Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice
Christianson, J. A., Ryals, J. M., McCarson, K. E., & Wright, D. E. (2003) · Journal of Pain · doi:10.1016/j.jpain.2003.07.002 · Cited by 59
Insulin‐like Growth Factor‐I and IGF‐I Receptors in Diabetic Patients with Neuropathy
Migdalis, I. N., Kalantzis, L., Samartzis, M., Kalogeropoulou, K., Nounopoulos, C., & Bouloukos, A. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb02086.x · Cited by 59
Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700008 · Cited by 58
Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy
Obrosova, I. G., & Julius, U. (2005) · Current Vascular Pharmacology · doi:10.2174/1570161054368634 · Cited by 58
Kato, N., Mizuno, K., Makino, M., Suzuki, T., & Yagihashi, S. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00164-9 · Cited by 58
Adriaensen, H. A., Plaghki, L., Mathieu, C., Joffroy, A., & Vissers, K. C. P. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.552 · Cited by 57
Tesfaye, S. H., Tandan, R., Bastyr, E. J., Kles, K. A., Skljarevski, V., Price, K. L., & for the Ruboxistaurin Study Group (2007) · Diabetes Care · doi:10.2337/dc07-0608 · Cited by 55
Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients.
Jermendy, G., Tóth, L., Vörös, P., et al. (1991) · PubMed · Cited by 55
Aldose reductase inhibition in the treatment of diabetic neuropathy: Where are we in 2004?
Gabbay, K. H. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0047-z · Cited by 54
Delcroix, J., Tomlinson, D. R., & Fernyhough, P. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00215-5 · Cited by 53
Dietary Zinc Deficiency Decreases Plasma Concentrations of Vitamin E
Bunk, M. J., Dnistrian, A. M., Schwartz, M. K., & Rivlin, R. S. (1989) · Experimental Biology and Medicine · doi:10.3181/00379727-190-42876 · Cited by 53
Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats
Rodríguez‐Peña, A., Botana, M., González, M., & Requejo, F. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12067-e · Cited by 52
Arikawa, E., Ronald, C. W., Isshiki, K., Luptak, I., He, Z., Yasuda, Y., Maeno, Y., Patti, M., Weir, G. C., Harris, R. A., et al. (2007) · Diabetes · doi:10.2337/db06-0655 · Cited by 52
Maggitti, K. W., Lee, J., Conejero, A., Schmidt, A. M., Grant, R., & Breitbart, A. S. (2004) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000122857.49274.8c · Cited by 51
Sango, K., Verdes, J. M., Hikawa, N., Horie, H., Tanaka, S., Inoue, S., Sotelo, J. R., & Takenaka, T. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90087-6 · Cited by 51
Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?
Malik, R. A. (2000) · Annals of Medicine · doi:10.3109/07853890008995903 · Cited by 51
Didangelos, T., Arsos, G. A., Karamitsos, D. T., Athyros, V. G., Georga, S., & Karatzas, N. D. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.05.002 · Cited by 50
The Evidence Base for Diabetes Care
Herman, W. H., Kinmonth, A. L., Wareham, N. J., & Williams, R. (2010) · doi:10.1002/9780470682807.ch1 · Cited by 50
C‐peptide improves neuropathy in type 1 diabetic BB/Wor‐rats
Zhang, W., Kamiya, H., Ekberg, K., Wahren, J., & Sima, A. A. F. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.672 · Cited by 48
BDNF Attenuates Functional and Structural Disorders in Nerves of Galactose-fed Rats
Mizisin, A. P., Bache, M., DiStefano, P. S., Acheson, A. L., Lindsay, R. M., & Calcutt, N. A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199712000-00004 · Cited by 48
Efficacy of Alrestatin, An Aldose Reductase Inhibitor, in Human Diabetic and Nondiabetic Lenses
Chylack, L. T., Henriques, H. F., Cheng, H., & Tung, W. H. (1979) · Ophthalmology · doi:10.1016/s0161-6420(79)35364-7 · Cited by 47
Self-citationElias, K. A., Cronin, M. J., Stewart, T. A., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1637 · Cited by 47
Jensen, M. P., Dworkin, R. H., Gammaitoni, A. R., Olaleye, D. O., Oleka, N. A., & Galer, B. S. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.02.012 · Cited by 46
The Evidence Base for Diabetes Care
(2002) · Wiley eBooks · doi:10.1002/0470846585 · Cited by 45
Miyauchi, Y., Shikama, H., Takasu, T., Okamiya, H., Umeda, M., Hirasaki, E., Ohata, I., Nakayama, H., & Nakagawa, S. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340467 · Cited by 44
Impaired production of nerve growth factor in the submandibular gland of diabetic mice
Kasayama, S., & Oka, T. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.3.e400 · Cited by 43
Insulin-Like Growth Factors in the Treatment of Neurological Disease
Leinninger, G. M., & Feldman, E. L. (2005) · KARGER eBooks · doi:10.1159/000085763 · Cited by 42
Self-citationArrieta, O. G., García-Navarrete, R., Zúñiga, S., Ordóñez, G., Virgen‐Ortiz, A., Palencia, G., Morales-Espinosa, D., Hernández‐Pedro, N., & Sotelo, J. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01467.x · Cited by 42
Delcroix, J., Michael, G. J., Priestley, J. V., Tomlinson, D. R., & Fernyhough, P. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1779 · Cited by 42
Thamotharampillai, K., Chan, A. K. F., Bennetts, B., Craig, M. E., Cusumano, J. M., Silink, M., Oates, P. J., & Donaghue, K. C. (2006) · Diabetes Care · doi:10.2337/dc06-0678 · Cited by 42
Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription
Tamási, V., Jeffries, J. M., Arteel, G. E., & Falkner, K. C. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.07.030 · Cited by 41
Strokov, I. A., Manukhina, E. B., Bakhtina, L. Y., et al. (2000) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1002874125993 · Cited by 39
Autonomic neuropathy in diabetic children
Verrotti, A., Chiarelli, F., Blasetti, A., & Morgese, G. (1995) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1995.tb00881.x · Cited by 38
Olchovsky, D., BRUNO, J. F., Gelato, M. C., et al. (1991) · Endocrinology · doi:10.1210/endo-128-2-923 · Cited by 38
Schmidt, R. E., Plurad, S. B., Saffitz, J. E., Grabau, G. G., & Yip, H. K.-F. (1985) · Diabetes · doi:10.2337/diab.34.12.1230 · Cited by 37
Identification of Changes in Gene Expression in Dorsal Root Ganglia in Diabetic Neuropathy
Price, S. A., Zeef, L. A. H., Wardleworth, L., Hayes, A., & Tomlinson, D. R. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000228199.89420.90 · Cited by 34
Regenerative arrest of inflamed peripheral nerves: role of nitric oxide
McDonald, D. S., Cheng, C., Martinez, J. A., & Zochodne, D. W. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f03fff · Cited by 34
Birrell, A., Heffernan, S. J., Ansselin, A. D., et al. (2000) · Diabetologia · doi:10.1007/s001250050014 · Cited by 34
Little, A. A., Edwards, J. L., & Feldman, E. L. (2007) · PubMed · Cited by 34
Self-citationTankova, T. I., Koev, D. J., & Dakovska, L. N. (2004) · PubMed · Cited by 32
Hirakata, Y., & Kitamura, S. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.2260560.x · Cited by 31
Combination of vitamin c and rutin on neuropathy and lung damage of diabetes mellitus rats
Je, H. D., Shin, C. Y., Park, S. Y., Yim, S. H., Kum, C., Huh, I. H., Kim, J. H., & Sohn, U. D. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976561 · Cited by 31
Sharma, S., Kulkarni, S., & Chopra, K. (2006) · PubMed · Cited by 30
Cameron, N. E., & Cotter, M. A. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.3.e471 · Cited by 26
Molecular approaches to chronic kidney disease
Schmid, H., Henger, A., & Kretzler, M. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000214770.11609.fb · Cited by 24
Identification and Characterization of Compounds That Potentiate NT-3-Mediated Trk Receptor Activity
Lewis, M. A., Hunihan, L., Franco, D., Robertson, B., Palmer, J., Laurent, D. R. S., Balasubramanian, B. N., Li, Y., & Westphal, R. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020255 · Cited by 21
The management of lower-extremity diabetic ulcers.
Gonzalez, E. R., & Oley, M. A. (2000) · PubMed · Cited by 21
Woźniak, K., Arabski, M., Malecka-Panas, E. I., Drzewoski, J., & Błasiak, J. (2004) · PubMed · Cited by 20
Schmidt, R. E., Plurad, S. B., Saffitz, J. E., et al. (1985) · Diabetes · doi:10.2337/diabetes.34.12.1230 · Cited by 19
Diabetic Peripheral and Autonomic Neuropathy
Feldman, E. L., Stevens, M. J., & Russell, J. W. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_24 · Cited by 18
Self-citationCNTFR α alone or in combination with CNTF promotes macrophage chemotaxis in vitro
Kobayashi, H., & Mizisin, A. P. (2000) · Neuropeptides · doi:10.1054/npep.2000.0829 · Cited by 17
Podar, T., & Tuomilehto, J. O. (2002) · Drugs · doi:10.2165/00003495-200262140-00001 · Cited by 14
Han, H. J., Kang, C. W., & Park, S. H. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04495.x · Cited by 14
New phosphodiesterase inhibitors in the treatment of erectile dysfunction
Anderson, P. C., Gommersall, L. M., Hayne, D., Arya, M., & PATEL, H. R. H. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.11.2241 · Cited by 13
Effect of IGF-I and neurotrophin-3 on gracile neuroaxonal dystrophy in diabetic and aging rats
Schmidt, R. E., Dorsey, D. A., Beaudet, L. N., Plurad, S. B., Parvin, C. A., & Ohara, S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02602-0 · Cited by 10
Dorchy, H. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00035-5 · Cited by 7
Commentary: Botanical Potentials in Alzheimer's Disease
Perry, E. K. (2007) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.6405 · Cited by 6
Cited by
for the European Depression in Diabetes (EDID) Research Consortium, Nouwen, A., Winkley, K., Twisk, J., Lloyd, C. E., Peyrot, M., Ismail, K., & Pouwer, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1874-x · Cited by 756
“However, because antidepressant medication is prescribed for other problems, such as neuropathic pain [36, 37] or sedation, this also may have artificially increased the incidence rate, particularly among people with diabetes.”
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 566
Self-citationMolecular pathways associated with oxidative stress in diabetes mellitus
Ighodaro, O. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.058 · Cited by 555
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Cardiac Autonomic Neuropathy in Diabetes
Pop-Busui, R. (2010) · Diabetes Care · doi:10.2337/dc09-1294 · Cited by 476
Metadata
- Authors
- Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 120
- Issue
- 1
- Pages
- 1-34
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1983072558
- Cited by
- 790
- References
- 392
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.